Procter Gamble Ownership

PG Stock  USD 169.13  2.22  1.33%   
Procter Gamble owns a total of 2.34 Billion outstanding shares. Over half of Procter Gamble's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. On March 11, 2025, Representative Lloyd Doggett of US Congress acquired under $15k worth of Procter Gamble's common stock.
 
Shares in Circulation  
First Issued
1985-09-30
Previous Quarter
2.5 B
Current Value
2.5 B
Avarage Shares Outstanding
2.8 B
Quarterly Volatility
219.5 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.

Procter Stock Ownership Analysis

About 70.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 6.28. Procter Gamble last dividend was issued on the 21st of April 2025. The entity had 2:1 split on the 21st of June 2004. The Procter Gamble Company provides branded consumer packaged goods worldwide. The Procter Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio. Procter Gamble operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 106000 people. To find out more about Procter Gamble contact Fama Francisco at 513 983 1100 or learn more at https://www.pginvestor.com.
Besides selling stocks to institutional investors, Procter Gamble also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Procter Gamble's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Procter Gamble's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Procter Gamble Quarterly Liabilities And Stockholders Equity

122.64 Billion

Procter Gamble Insider Trades History

Less than 1% of Procter Gamble are currently held by insiders. Unlike Procter Gamble's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Procter Gamble's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Procter Gamble's insider trades
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Procter Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Procter Gamble is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Procter Gamble backward and forwards among themselves. Procter Gamble's institutional investor refers to the entity that pools money to purchase Procter Gamble's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Franklin Resources Inc2024-12-31
20.2 M
Bank Of New York Mellon Corp2024-12-31
19.3 M
T. Rowe Price Associates, Inc.2024-12-31
19 M
Fisher Asset Management, Llc2024-12-31
18.7 M
Royal Bank Of Canada2024-12-31
17.2 M
Goldman Sachs Group Inc2024-12-31
16.9 M
Charles Schwab Investment Management Inc2024-12-31
16.9 M
Ubs Asset Mgmt Americas Inc2024-12-31
16.3 M
Legal & General Group Plc2024-12-31
16.2 M
Vanguard Group Inc2024-12-31
229.8 M
Blackrock Inc2024-12-31
176.2 M
Note, although Procter Gamble's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Procter Gamble Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Procter Gamble insiders, such as employees or executives, is commonly permitted as long as it does not rely on Procter Gamble's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Procter Gamble insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Procter Gamble's latest congressional trading

Congressional trading in companies like Procter Gamble, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Procter Gamble by those in governmental positions are based on the same information available to the general public.
2025-03-11Representative Lloyd DoggettAcquired Under $15KVerify
2025-03-10Representative Jefferson ShreveAcquired $50K to $100KVerify
2025-02-12Representative Emily RandallAcquired Under $15KVerify
2024-12-06Representative Ro KhannaAcquired Under $15KVerify
2024-12-05Representative Lloyd DoggettAcquired Under $15KVerify
2024-09-09Representative Lloyd DoggettAcquired Under $15KVerify
2024-09-06Representative John JamesAcquired Under $15KVerify
2024-09-02Representative John JamesAcquired Under $15KVerify
2024-08-21Representative Jared MoskowitzAcquired Under $15KVerify
2024-08-20Representative Scott FranklinAcquired Under $15KVerify
2024-08-16Representative Kathy ManningAcquired Under $15KVerify
2024-06-13Senator Tommy TubervilleAcquired Under $15KVerify
2024-06-05Representative Lloyd DoggettAcquired Under $15KVerify
2024-04-25Representative Dan NewhouseAcquired Under $15KVerify
2024-04-05Representative Ro KhannaAcquired Under $15KVerify
2024-03-05Representative Lloyd DoggettAcquired Under $15KVerify
2024-02-13Senator Tommy TubervilleAcquired Under $15KVerify
2024-02-06Representative Kathy ManningAcquired Under $15KVerify
2024-02-05Representative Ro KhannaAcquired Under $15KVerify
2023-12-18Representative Lloyd DoggettAcquired Under $15KVerify
2023-12-15Representative John CurtisAcquired Under $15KVerify
2023-10-31Senator Markwayne MullinAcquired Under $15KVerify
2023-10-20Senator Pete RickettsAcquired $100K to $250KVerify
2023-10-12Representative Scott FranklinAcquired $15K to $50KVerify
2023-10-11Senator Markwayne MullinAcquired $15K to $50KVerify
2023-09-30Representative Robert J WittmanAcquired Under $15KVerify
2023-09-08Representative Lloyd DoggettAcquired Under $15KVerify
2023-08-13Senator Tommy TubervilleAcquired Under $15KVerify
2023-06-14Senator Tommy TubervilleAcquired Under $15KVerify
2023-06-07Representative Lloyd DoggettAcquired Under $15KVerify
2023-05-19Representative Kathy ManningAcquired Under $15KVerify
2023-03-13Representative John CurtisAcquired Under $15KVerify
2023-03-06Representative Lloyd DoggettAcquired Under $15KVerify
2023-03-02Representative Diana HarshbargerAcquired Under $15KVerify
2023-02-14Representative Kevin HernAcquired Under $15KVerify
2023-01-13Senator Tommy TubervilleAcquired Under $15KVerify
2022-12-06Representative Lloyd DoggettAcquired Under $15KVerify
2022-11-03Representative Virginia FoxxAcquired $50K to $100KVerify
2022-10-29Representative Diana HarshbargerAcquired Under $15KVerify
2022-09-14Representative Kathy ManningAcquired Under $15KVerify
2022-09-06Representative Lloyd DoggettAcquired Under $15KVerify
2022-09-02Representative Carol Devine MillerAcquired Under $15KVerify
2022-08-31Representative Diana HarshbargerAcquired Under $15KVerify
2022-08-15Representative Debbie DingellAcquired Under $15KVerify
2022-08-05Representative Virginia FoxxAcquired $15K to $50KVerify
2022-07-28Representative Diana HarshbargerAcquired Under $15KVerify
2022-06-29Representative Diana HarshbargerAcquired Under $15KVerify
2022-06-20Representative Marjorie Taylor GreeneAcquired Under $15KVerify
2022-06-06Representative Lloyd DoggettAcquired Under $15KVerify
2022-05-26Representative Diana HarshbargerAcquired Under $15KVerify
2022-03-16Representative John RutherfordAcquired Under $15KVerify
2022-03-07Representative Lloyd DoggettAcquired Under $15KVerify
2022-02-14Senator Tommy TubervilleAcquired $15K to $50KVerify
2022-02-11Representative Pete SessionsAcquired $15K to $50KVerify
2021-12-06Representative Lloyd DoggettAcquired Under $15KVerify
2021-11-05Representative Kathy ManningAcquired Under $15KVerify
2021-09-07Representative Lloyd DoggettAcquired Under $15KVerify
2021-07-13Representative Ro KhannaAcquired Under $15KVerify
2021-07-08Representative Katherine M ClarkAcquired Under $15KVerify
2021-06-30Representative Lloyd DoggettAcquired Under $15KVerify
2021-04-27Representative William R KeatingAcquired Under $15KVerify
2021-03-16Representative Peter MeijerAcquired $15K to $50KVerify
2021-03-08Representative Lloyd DoggettAcquired Under $15KVerify
2021-02-23Representative Peter MeijerAcquired Under $15KVerify
2021-02-17Representative Chris JacobsAcquired Under $15KVerify
2020-12-09Representative Joseph D MorelleAcquired Under $15KVerify
2020-12-08Senator Bill CassidyAcquired Under $15KVerify
2020-12-07Representative Lloyd DoggettAcquired Under $15KVerify
2020-09-14Representative Carol Devine MillerAcquired $15K to $50KVerify
2020-09-08Representative Lloyd DoggettAcquired Under $15KVerify
2020-08-15Representative Kevin HernAcquired Under $15KVerify
2020-08-13Representative Daniel MeuserAcquired Under $15KVerify
2020-06-25Representative Robert C Bobby ScottAcquired Under $15KVerify
2020-06-18Representative Gerald E ConnollyAcquired Under $15KVerify
2020-06-03Representative Lloyd DoggettAcquired Under $15KVerify
2020-04-09Representative John CurtisAcquired Under $15KVerify
2020-04-05Senator David PerdueAcquired $15K to $50KVerify
2020-03-04Representative Lloyd DoggettAcquired Under $15KVerify
2020-02-08Representative Mike GallagherAcquired $15K to $50KVerify
2020-01-23Senator James InhofeAcquired $100K to $250KVerify
2019-12-09Representative Lloyd DoggettAcquired Under $15KVerify
2019-11-05Senator David PerdueAcquired $15K to $50KVerify
2019-09-06Representative Lloyd DoggettAcquired Under $15KVerify
2019-08-11Senator Pat ToomeyAcquired $15K to $50KVerify
2019-08-07Senator Bill CassidyAcquired Under $15KVerify
2019-06-06Representative Lloyd DoggettAcquired Under $15KVerify
2019-06-04Senator David PerdueAcquired Under $15KVerify
2019-03-25Senator Sheldon WhitehouseAcquired Under $15KVerify
2019-03-06Senator David PerdueAcquired $15K to $50KVerify
2019-01-13Senator Pat ToomeyAcquired $15K to $50KVerify
2019-01-11Senator Shelley Moore CapitoAcquired Under $15KVerify
2019-01-10Senator Shelley Moore CapitoAcquired Under $15KVerify
2019-01-09Senator David PerdueAcquired Under $15KVerify
2018-12-04Representative Lloyd DoggettAcquired Under $15KVerify
2018-11-08Senator David PerdueAcquired Under $15KVerify
2018-10-15Senator Pat ToomeyAcquired $15K to $50KVerify
2018-10-05Representative Lloyd DoggettAcquired Under $15KVerify
2018-09-07Senator Pat ToomeyAcquired $15K to $50KVerify
2018-09-05Representative Lloyd DoggettAcquired Under $15KVerify
2018-07-04Senator David PerdueAcquired $15K to $50KVerify
2018-06-06Representative Lloyd DoggettAcquired Under $15KVerify
2018-05-15Senator Bill CassidyAcquired Under $15KVerify
2018-05-10Representative K Michael ConawayAcquired Under $15KVerify
2018-05-03Senator David PerdueAcquired $15K to $50KVerify
2018-05-01Senator David PerdueAcquired $15K to $50KVerify
2018-02-10Senator Shelley Moore CapitoAcquired Under $15KVerify
2018-02-01Senator David PerdueAcquired $50K to $100KVerify
2017-12-20Senator Angus KingAcquired Under $15KVerify
2017-12-19Senator Pat ToomeyAcquired $15K to $50KVerify
2017-12-05Senator Bill CassidyAcquired Under $15KVerify
2017-11-29Senator Pat ToomeyAcquired $15K to $50KVerify
2017-03-01Senator David PerdueAcquired $15K to $50KVerify
2016-09-30Senator David PerdueAcquired Under $15KVerify
2016-08-31Senator David PerdueAcquired Under $15KVerify
2016-08-12Senator David PerdueAcquired Under $15KVerify
2016-08-11Senator David PerdueAcquired $15K to $50KVerify
2016-07-27Senator Bill CassidyAcquired Under $15KVerify
2016-07-12Senator Pat ToomeyAcquired $15K to $50KVerify
2016-06-16Senator Pat ToomeyAcquired $15K to $50KVerify
2016-06-07Senator James InhofeAcquired $50K to $100KVerify
2016-05-02Senator Bill CassidyAcquired Under $15KVerify
2016-02-02Senator David PerdueAcquired $15K to $50KVerify
2015-09-24Senator Sheldon WhitehouseAcquired Under $15KVerify
2015-09-08Senator David PerdueAcquired $15K to $50KVerify
2015-06-26Senator David PerdueAcquired Under $15KVerify
2015-06-04Senator David PerdueAcquired Under $15KVerify
2015-05-28Senator James InhofeAcquired $15K to $50KVerify
2015-05-20Senator Pat ToomeyAcquired $15K to $50KVerify
2014-06-27Senator Susan M CollinsAcquired Under $15KVerify

Procter Gamble Outstanding Bonds

Procter Gamble issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Procter Gamble uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Procter bonds can be classified according to their maturity, which is the date when Procter Gamble has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Procter Gamble Corporate Filings

8K
8th of April 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
12th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
6th of March 2025
Other Reports
ViewVerify
26th of November 2024
Other Reports
ViewVerify

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Household Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.341
Dividend Share
3.96
Earnings Share
6.28
Revenue Per Share
35.775
Quarterly Revenue Growth
0.021
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.